Olshan Represents Client in $75 Million Registered Rights Offering

Firm News

Olshan represented Summit Therapeutics Inc. (NASDAQ: SMMT), a clinical-stage drug discovery and development company, in the commencement of its rights offering earlier this week. The rights offering to purchase shares of Summit’s common stock has a total offering value of up to $75 million. Corporate associate Zachary Freedman assisted in this matter.

Media Contact

Marketing Contact
Mizi Mehaj
Marketing & Administrative Manager

Jump to Page

Necessary Cookies

Necessary cookies enable core functionality such as security, network management, and accessibility. You may disable these by changing your browser settings, but this may affect how the website functions.

Analytical Cookies

Analytical cookies help us improve our website by collecting and reporting information on its usage. We access and process information from these cookies at an aggregate level.